A phase I study of recombinant interleukin 2 plus recombinant beta-interferon.
Year: 1988
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: R L Krigel, K A Padavic-Shaller, A R Rudolph, S Litwin, M Konrad, E C Bradley, R L Comis
Institution: Fox Chase Cancer Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2155585300